| Patents for A61K 49 - Preparations for testing in vivo (35,376) |
|---|
| 01/04/2007 | WO2006121631A3 Real time imaging during solid organ transplant |
| 01/04/2007 | WO2005089436A3 Genetic networks regulated by attenuated gh/igf1 signaling and caloric restriction |
| 01/04/2007 | US20070006331 Mouse models of human prostate cancer |
| 01/04/2007 | US20070003569 Recombinant polypeptides, which can be used as purified antigens for the detection and control of tuberculosis |
| 01/04/2007 | US20070003485 Microbubble-generating carbohydrate microparticles encapsulated in biodegradable, crosslinked protein shells for enhanced echocardiographic imaging |
| 01/04/2007 | US20070003484 Hydroxypyridinone derivatives, metal complexes thereof and the use thereof for preparing conjugates with biomolecules |
| 01/04/2007 | US20070003483 Method of evaluating organ function |
| 01/04/2007 | US20070003482 Ultrasound contrast agents for molecular imaging |
| 01/04/2007 | US20070003481 Method and composition to individualize Levodopa/Carbidopa therapy using a breath test |
| 01/04/2007 | US20070003480 Liposomal composition comprising haptotactic peptides |
| 01/04/2007 | US20070003479 Diagnostic imaging contrast agents with extended blood retention |
| 01/04/2007 | DE10260372B4 Kernspintomographievorrichtung und Verfahren zur ortsaufgelösten Bilddarstellung Magnetic resonance imaging apparatus and method for spatially resolved imaging |
| 01/04/2007 | DE102005030492A1 Intravascular echo contrast agents, useful as clinical diagnostics in imaging techniques, comprises an aqueous based poloxamer preparation |
| 01/04/2007 | DE102005029897A1 Picture giving procedure with optical coherence tomography catheter for visualizing molecular functional processes in vulnerable plaques of a blood vessel of a patient, comprises producing tomography picture of contrast agent-marked plaque |
| 01/04/2007 | CA2619034A1 Optical imaging of rheumatoid arthritis |
| 01/03/2007 | EP1739185A1 Serum biomarkers in lung cancer |
| 01/03/2007 | EP1738774A1 Compositions comprising magnetic iron oxide particles and use thereof in medical imaging |
| 01/03/2007 | EP1738773A1 Composition comprising magnetic iron oxide particles and use thereof in medical imaging |
| 01/03/2007 | EP1737499A2 Treatment of chronic obstructive pulmonary disease by low dose inhalation of protease inhibitor |
| 01/03/2007 | EP1737497A2 Nucleic acid aptamers conjugated to high molecular weight steric groups |
| 01/03/2007 | EP1737474A2 Non-gmo metal amino acid chelates and non-gmo metal amino acid chelate-containing compositions |
| 01/03/2007 | EP1737428A1 Macromolecular delivery systems for non-invasive imaging, evaluation and treatment of arthritis and other inflammatory diseases |
| 01/03/2007 | EP1411991B1 Methods of determining the effects of botulinum toxins |
| 01/03/2007 | EP1410014B1 Method for sample identification in a mammal as well as a kit for performing this method |
| 01/03/2007 | CN1890384A Use of genetic polymorphisms that associate with efficacy of treatment of inflammatory disease |
| 01/02/2007 | USRE39456 Radioactive embolizing compositions |
| 01/02/2007 | US7157436 An specific oligonucleotide sequence conataining 2-20 base 3'OH, 5'OH synthetic oligonucleotide which induces a response selected from cell cycle arrest, inhibition of cell proliferation, activation of caspases in cancer cells |
| 01/02/2007 | US7157235 Involving the detection of an elevated amount of Macrophage Inhibitory Cytokine-1 (MIC-1) in a test body sample |
| 01/02/2007 | CA2326713C Use of a papillary fibroblast-specific paratope as a skin quality marker |
| 12/28/2006 | WO2006138698A2 Metal-enhanced fluorescence-based sensing methods |
| 12/28/2006 | WO2006138366A2 Protein markers |
| 12/28/2006 | WO2006136564A1 Multidentate aza ligands able to complex metal ions and the use thereof in diagnostics and therapy |
| 12/28/2006 | WO2006119645B1 Marker device for x-ray, ultrasound and mr imaging |
| 12/28/2006 | WO2005110489A3 Nucleic acid aptamers conjugated to high molecular weight steric groups |
| 12/28/2006 | US20060292660 Drug screening; administering albumin attached to alcohol, organic acid, saccharide or amino acid and determining amount administered to the subject or degradation product or metabolite that migrated into the blood and/or is excreted out of the body |
| 12/28/2006 | US20060292563 Methods of diagnosing & treating diabetes and insulin resistance |
| 12/28/2006 | US20060292079 Conjugates of hydroxypyridinone derivative metal complexes with biomolecules and their use for MRI diagnosis |
| 12/28/2006 | US20060292078 Optical imaging of colorectal cancer |
| 12/28/2006 | US20060292077 Dendritic and star-shaped contrast agents for medical devices and bioabsorbable radiopaque bulk material and method for producing same |
| 12/28/2006 | US20060292076 Antimicrobial mediated ozone generation |
| 12/28/2006 | US20060292075 Labelled glutamine and lysine analogues |
| 12/28/2006 | CA2611969A1 Method for identifying modulators of keah6 useful for treating alzheimer's disease |
| 12/27/2006 | EP1735463A2 Biomarkers and methods for determining sensitivity to epidermal growth factor receptor modulators in non-small cell lung cancer |
| 12/27/2006 | EP1735012A2 Targeting of radioimagining and radiotherapy agents |
| 12/27/2006 | EP1381604B1 Amyloid plaque aggregation inhibitors and diagnostic imaging agents |
| 12/27/2006 | EP1313695B1 Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy |
| 12/27/2006 | CN1883711A Solution and method for supporting patient imaging |
| 12/27/2006 | CN1291995C **Tc marked dopamine transport protein developer |
| 12/27/2006 | CN1291644C Model of endometriosis and modeling method |
| 12/26/2006 | US7153956 To provide IR dyes and inks tuned to near-IR wavelengths and, additionally, to provide near-IR dyes that are water-dispersible |
| 12/26/2006 | US7153955 Apparatus for use as diagnostic and therapeutic tool in gene therapy |
| 12/26/2006 | US7153951 A biologically active peptide at least 85% identical to a peptide: (a) X01ValSerGluX02GlnLeuX03HisX04X05GlyLysX06; (b) fragments containing amino acids 1-9, 1-10, 1-11, 1-12,(c) a salt or (d) N- or C- derivatives |
| 12/26/2006 | US7153841 Conjugates with carriers; red shifted absorption; antiproliferative and antitumor agents; benign prostatic hyperplasia; diagnosis |
| 12/26/2006 | US7153514 Use of botulinum toxin therapy for prostatic hyperplasia and related disorders |
| 12/26/2006 | US7153491 competitive binding assays useful in identification of enzyme inhibitors, used for the treatment of neurological disorders such as Alzheimer's disease |
| 12/21/2006 | WO2006135879A2 Diagnosis and prognosis of diabetes |
| 12/21/2006 | WO2006133903A2 Method, dye and medicament for staining the internal limiting memebrane, the vitreous and/or the capsule of an eye |
| 12/21/2006 | WO2006113347A3 Diagnostic and therapeutic potential of immune globulin intravenous (igiv) products |
| 12/21/2006 | WO2006088476A3 Carboranylporphyrins and uses thereof |
| 12/21/2006 | WO2006032705A3 Contrast agents encapsulating systems for cest imaging |
| 12/21/2006 | WO2005120586A3 Copolymers comprising positively and negatively charged aminoacids conjugated to chelants |
| 12/21/2006 | WO2005096789A3 Methods and compositions for imaging and biomedical applications |
| 12/21/2006 | WO2005068359A3 Method for enriching hyper-polarized atom nuclei and method for carrying out said method |
| 12/21/2006 | WO2005018535A3 Compositions and methods for treatment of severe acute respiratory syndrome (sars) |
| 12/21/2006 | US20060286037 Heart-slowing drug containing short-acting ß blocker as the active ingredient |
| 12/21/2006 | US20060286036 Methods and compositions for inhibiting HIV infection |
| 12/21/2006 | US20060286035 Methods and compositions for modulating the interaction between adiponectin and its receptor |
| 12/21/2006 | US20060286034 Oligosaccharide biomarkers for mucopolysaccharidoses and other related disorders |
| 12/21/2006 | US20060286031 Modulators of tissue regeneration |
| 12/21/2006 | CA2612297A1 Method, dye and medicament for staining the internal limiting membrane, the vitreous and/or the capsule of an eye |
| 12/21/2006 | CA2611033A1 Diagnosis and prognosis of diabetes |
| 12/20/2006 | EP1733744A1 Method, dye and medicament for staining the internal limiting membrane and/or the capsule of an eye |
| 12/20/2006 | EP1732650A1 Composition and method for cancer treatment |
| 12/20/2006 | EP1732601A1 Cytotoxicity mediation of cells evidencing surface expression of cd44 |
| 12/20/2006 | EP1732594A2 Method for the delivery of sustained release agents |
| 12/20/2006 | EP1732584A2 Multi-component biological transport systems |
| 12/20/2006 | EP1318845B1 Hydrophilic, lubricious medical devices having contrast for magnetic resonance imaging |
| 12/20/2006 | EP1194164B1 Prion protein peptides and uses thereof |
| 12/20/2006 | EP1147111B1 Cryptate compounds and methods for diagnosis and therapy |
| 12/20/2006 | CN1882364A Contrast agent for medical imaging techniques and usage thereof |
| 12/20/2006 | CN1882363A Method of identifying responders to treatment with insulin sensitizers |
| 12/20/2006 | CN1879896A Paramagnetic metal manganese doped multi-complex as magnetic resonance imaging contrast agent |
| 12/20/2006 | CN1879895A Aqueous matrix CT negative contrast medium for digestive tract and its preparation method |
| 12/20/2006 | CN1879894A Method for establishing anti-hepatitis C virus drug screening experimental animal model |
| 12/20/2006 | CN1879893A Production method of epithelial tissue precancerosis transgenic animal model |
| 12/20/2006 | CN1879892A Method for establishing extranodal nasal type NK/T-celllymphoma animal model |
| 12/20/2006 | CN1879890A Use of methioninase in anti-methionine and anti-homocysteine chemotherapy |
| 12/19/2006 | US7151164 Genetic engineered, chimera and human monoclonal antibodies that bind to lymphocytes CD antigens, used for diagnosis and prohylaxis of cancer and autoimmune diseases |
| 12/19/2006 | US7151117 Administering a X-ray contrast media selected from iotrolan and iodixannol to an eye of a mammal suffering from allergic conjunctivitis and allergic rhinitis to decrease in histamine release; side effect reduction |
| 12/14/2006 | WO2006133354A2 Methods for producing nanoparticulate metal complexes and altering nanoparticle morphology |
| 12/14/2006 | WO2006132850A2 Polymeric marker with high radiopacity for use in medical devices |
| 12/14/2006 | WO2006132403A1 Mri contrast medium containing liposomes |
| 12/14/2006 | WO2006131292A2 Method for dissolution of gases with short-lived physical properties in a liquid |
| 12/14/2006 | WO2006131133A1 Optical irradiation device for the polarization of alkali metal atoms and a device for the hyperpolarization of noble gases |
| 12/14/2006 | WO2006023888A3 Imaging cellular nucleic acids |
| 12/14/2006 | WO2005105035A3 Targeted nanoparticles for drug delivery |
| 12/14/2006 | WO2005099775A3 Labeled anwexin for predicting the response to a therapeutic regimen |
| 12/14/2006 | WO2004055165A3 Glutathione-s-transferase test for susceptibility to parkinson's |
| 12/14/2006 | US20060281072 Stimulation of human T-cells and used to enhance antigen-specific immune responses; immunotherapy |
| 12/14/2006 | US20060280689 New MRI technique based on electron spin resonance and nitrogen endohedral C60 contrast agent |